1
–
15
of
173
results

Gibco™ Vitronectin (VTN-N) Recombinant Human Protein, Truncated
Vitronectin (VTN-N) is a recombinant human protein that provides a defined surface for feeder-free culture of human pluripotent stem cells (PSCs). When used with Essential 8™ Medium (A1517001), VTN-N has been proven to maintain pluripotency and normal growth characteristics in multiple PSC lines.
Content And Storage | Store at -80°C and protect from light. |
---|---|
Form | Liquid |
Protein Form | Recombinant |
Research Category | Stem Cell Research |
Concentration | 500 μg⁄ml |
For Use With (Application) | Stem Cell Culture |
Species | Human |
Protein Subtype | Vitronectin |
Recombinant | Recombinant |
Gibco™ Human EGF, Animal-Free Recombinant Protein, PeproTech®
Recombinant Protein
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | EGF |
Molecular Weight (g/mol) | 6.2 kDa |
Gene Symbol | EGF |
Endotoxin Concentration | <0.1 EU/ μg |
Sequence | NSDSECPLSH DGYCLHDGVC MYIEALDKYA CNCVVGYIGE RCQYRDLKWW ELR |
Expression System | E. coli |
For Use With (Application) | Functional Assay |
Source | E. coli |
Name | Human EGF, Animal-Free |
Accession Number | P01133 |
Regulatory Status | RUO |
Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
Biological Activity | The ED50 was determined by a cell proliferation assay using balb/c 3T3 cells is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Gene ID (Entrez) | 1950 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IFN gamma |
Molecular Weight (g/mol) | 16.8 kDa |
Gene Symbol | IFNG |
Endotoxin Concentration | <1 EU/ μg |
Sequence | MQDPYVKEAE NLKKYFNAGH SDVADNGTLF LGILKNWKEE SDRKIMQSQI VSFYFKLFKN FKDDQSIQKS VETIKEDMNV KFFNSNKKKR DDFEKLTNYS VTDLNVQRKA IHELIQVMAE LSPAAKTGKR KRSQMLFQGR RASQ |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human IFN-gamma |
Accession Number | P01579 |
Regulatory Status | RUO |
Gene Alias | BoIFNG; cytokine; EGK_03901; gamma interferon; gamma interferon precursor; gamma-interferon; gamma-interferon precursor (AA -23 to 143); H-IFN-g; IFG; IFI; IFN gamma; IFN ?; Ifng; IFN-g; IFNG2; IFN-gamma; IFN-gamma precursor; IFN-y; IFN?; Immune interferon; Interferon; interferon gamma; interferon gamma precursor; interferon gamma type 2; Interferon y; Interferon ?; interferon, gamma; interferon-gama; interferon-gamma; Interferon-gamma level; interferon-gamma precursor; Interferon?; M-IFN-g; R-IFN-g |
Biological Activity | The ED50 determined by a cytotoxicity assay using HT-29 cells is = 0.05 ng/ml, corresponding to a specific activity of = 2 x 10^7 units/mg |
Gene ID (Entrez) | 3458 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | BDNF |
Molecular Weight (g/mol) | 27 kDa |
Gene Symbol | BDNF |
Endotoxin Concentration | <1 EU/ μg |
Sequence | MHSDPARRGE LSVCDSISEW VTAADKKTAV DMSGGTVTVL EKVPVSKGQL KQYFYETKCN PMGYTKEGCR GIDKRHWNSQ CRTTQSYVRA LTMDSKKRIG WRFIRIDTSC VCTLTIKRGR |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human/Mouse/Rat BDNF |
Accession Number | P21237, P23363, P23560 |
Regulatory Status | RUO |
Gene Alias | abrineurin; ANON2; anorexia BDNF; Bdnf; BDNF precursor form; bdnf protein; brain derived neurothrophic factor; brain derived neurotrophic factor; brain-derived neurotrophic factor; BULN2; H-BDNF; neurotrophin; ProBDNF |
Biological Activity | Determined by its ability to bind recombinant human TrkB Fc Chimera in a functional ELISA. |
Gene ID (Entrez) | 12064, 24225, 627 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | TGF beta-1 |
Molecular Weight (g/mol) | 25 kDa |
Gene Symbol | Tgfb1 |
Endotoxin Concentration | <1 EU/ μg |
Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
Expression System | HEK293 cells |
For Use With (Application) | Functional Assay |
Source | HEK293 cells |
Name | Human TGF-beta 1 |
Accession Number | P01137 |
Regulatory Status | RUO |
Gene Alias | CED; cytokine; DPD1; LAP; Latency-associated peptide; prepro-transforming growth factor beta-1; regulatory protein; TGF b; TGF b 1; TGF beta; tgf beta 1; tgf beta1; TGF beta-1; TGF beta-1 protein; TGF β; TGF β 1; TGF β1; Tgfb; TGFB1; TGF-B1; Tgfb-1; TGFbeta; TGF-beta 1; TGF-beta 1 protein; TGFbeta1; TGF-beta1; TGF-beta-1; TGFβ1; Transforming growth factor; transforming growth factor b1; transforming growth factor beta; transforming growth factor beta 1; transforming growth factor beta-1; Transforming growth factor beta-1 proprotein; transforming growth factor beta-1 proprotein; transforming growth factor beta-1; transforming growth factor β1; transforming growth factor, beta 1; transforming growth factor, beta 1 (Camurati-Engelmann disease); transforming growth factor, beta-1; transforming growth factor-beta 1; transforming growth factor-beta I; transforming growth factor-beta-1; transforming growth factor-beta-1 precursor; unnamed protein product |
Biological Activity | The ED50 was determined by TGF-beta1's ability to inhibit the mouse IL-4-dependent proliferation of mouse HT-2 cells is ≤ 0.05 ng/ml, corresponding to a specific activity of ≥ 2 x 10^7 units/mg |
Gene ID (Entrez) | 7040 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | FGF2 |
Molecular Weight (g/mol) | 17.2 kDa |
Gene Symbol | FGF2 |
Endotoxin Concentration | <1 EU/ μg |
Sequence | AAGSITTLPA LPEDGGSGAF PPGHFKDPKR LYCKNGGFFL RIHPDGRVDG VREKSDPHIK LQLQAEERGV VSIKGVCANR YLAMKEDGRL LASKCVTDEC FFFERLESNN YNTYRSRKYT SWYVALKRTG QYKLGSKTGP GQKAILFLPM SAKS |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human FGF-basic (FGF-2/bFGF) (154 aa) |
Accession Number | P09038 |
Regulatory Status | RUO |
Gene Alias | Basic fibroblast growth factor; basic fibroblast growth factor bFGF; bFGF; FGF; fgf basic; Fgf2; Fgf-2; Fgfb; FGF-b; Fibroblast growth factor; fibroblast growth factor 2; fibroblast growth factor 2 (basic); HBGF-2; Heparin-binding growth factor 2; H-FGF-b-147; H-FGF-b-154; M-FGF-b; Prostatic growth factor; prostatropin |
Biological Activity | Determined by a cell proliferation assay using Balb/c 3T3 cells. The expected ED50 is ≤ 0.1 ng/ml, corresponding to a specific activity of ≥ 1 x 10^7 units/mg |
Gene ID (Entrez) | 2247 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Purity or Quality Grade | ≥ 95% by SDS-PAGE gel and HPLC analyses. |
---|---|
Conjugate | Unconjugated |
Form | Lyophilized |
Gene Symbol | RSPO1 |
Sequence | SRGIKGKRQR RISAEGSQAC AKGCELCSEV NGCLKCSPKL FILLERNDIR QVGVCLPSCP PGYFDARNPD MNKCIKCKIE HCEACFSHNF CTKCKEGLYL HKGRCYPACP EGSSAANGTM ECSSPAQCEM SEWSPWGPCS KKQQLCGFRR GSEERTRRVL HAPVGDHAAC SDTKETRRCT VRRVPCPEGQ KRRKGGQGRR ENANRNLARK ESKEAGAGSR RRKGQQQQQQ QGTVGPLTSA GPA |
For Use With (Application) | Functional Assay |
Source | CHO cells |
Name | Human R-Spondin 1 |
Accession Number | Q2MKA7 |
Regulatory Status | RUO |
Gene Alias | CRISTIN3; cristin-3; cysteine-rich and single thrombospondin domain-containing protein 3; FLJ40906; hRspo1; mCristin-3; RGD1565558; Roof plate-specific spondin-1; RP11-566C13.1; RSPO; RSPO1; Rspondin; R-spondin; R-spondin 1; R-spondin homolog; R-spondin homolog (Xenopus laevis); R-spondin-1; thrombospondin type 1 domain containing gene Rspondin |
Gene ID (Entrez) | 284654 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | GDNF |
Molecular Weight (g/mol) | 30.4 kDa |
Gene Symbol | GDNF |
Endotoxin Concentration | <1 EU/ μg |
Sequence | MSPDKQMAVL PRRERNRQAA AANPENSRGK GRRGQRGKNR GCVLTAIHLN VTDLGLGYET KEELIFRYCS GSCDAAETTY DKILKNLSRN RRLVSDKVGQ ACCRPIAFDD DLSFLDDNLV YHILRKHSAK RCGCI |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human GDNF |
Accession Number | P39905 |
Regulatory Status | RUO |
Gene Alias | AI385739; Astrocyte-derived trophic factor; ATF; ATF1; ATF2; Gdnf; glial cell derived neurotrophic factor; glial cell line derived neurotrophic factor; Glial cell line derived neutrophic factor; glial cell line-derived neurotrophic factor; gndf; HFB1-GDNF; hGDNF; H-GDNF; HSCR3; mGDNF; neurotrophic factor |
Biological Activity | Determined by a cell proliferation assay using SH-SY5Y cells. The expected ED50 for this effect is 1.0-10.0 ng/ml |
Gene ID (Entrez) | 2668 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IL-4 |
Molecular Weight (g/mol) | 15.1 kDa |
Gene Symbol | Il4 |
Endotoxin Concentration | <1 EU/ μg |
Sequence | MHKCDITLQE IIKTLNSLTE QKTLCTELTV TDIFAASKNT TEKETFCRAA TVLRQFYSHH EKDTRCLGAT AQQFHRHKQL IRFLKRLDRN LWGLAGLNSC PVKEANQSTL ENFLERLKTI MREKYSKCSS |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human IL-4 |
Accession Number | P05112 |
Regulatory Status | RUO |
Gene Alias | B cell growth factor 1; B_cell stimulatory factor 1; B-cell growth factor 1; B-cell IgG differentiation factor; B-cell stimulatory factor 1; BCGF1; BCGF-1; binetrakin; BSF1; BSF-1; cytokine; H-IL-4; IGG1 induction factor; IL2; IL4; Il-4; Il4e12; ILN; Interleukin; interleukin 4; interleukin 4 variant 2; interleukin 4 variant IL-4 delta2; interleukin 4 variant IL-4 delta3; interleukin 4 variant IL-4 int2A; interleukin 4 variant IL-4 int3A; interleukin 4 variant IL-4 int3B; Interleukin4; interleukin-4; interleukin-4 precursor; lymphocyte stimulatory factor 1; MGC79402; M-IL-4; Pitrakinra |
Biological Activity | The ED50 as determined by the dose-dependent stimulation of human TF-1 cells is ≤ 0.2 ng/ml, corresponding to a specific activity of ≥ 5 x 10^6 units/mg |
Gene ID (Entrez) | 3565 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Gibco™ Human TGF-beta 1 Recombinant Protein, PeproTech®
Recombinant Protein
Accession Number | P01137 |
---|---|
Regulatory Status | RUO |
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Gene ID (Entrez) | 7040 |
Formulation | protein with no preservative |
Gene Symbol | Tgfb1 |
Sequence | ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS |
For Use With (Application) | Functional Assay |
Source | CHO cells |
Recombinant | Recombinant |
Name | Human TGF-beta 1 |
Content And Storage | -20°C |
---|---|
Purity or Quality Grade | ≥ 98% by SDS-PAGE gel and HPLC analyses. |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | IL-13 |
Molecular Weight (g/mol) | 12.6 kDa |
Gene Symbol | Il13 |
Endotoxin Concentration | <1 EU/ μg |
Sequence | MSPGPVPPST ALRELIEELV NITQNQKAPL CNGSMVWSIN LTAGMYCAAL ESLINVSGCS AIEKTQRMLS GFCPHKVSAG QFSSLHVRDT KIEVAQFVKD LLLHLKKLFR EGRFN |
Expression System | E. coli |
For Use With (Application) | ELISA,Functional Assay,Western Blot |
Source | E. coli |
Name | Human IL-13 |
Accession Number | P35225 |
Regulatory Status | RUO |
Gene Alias | ALRH; ALRH antibody; BHR1; il 13; Il13; Il-13; IL-13; cytokine; ILN; Interleukin; interleukin 13; Interleukin13; interleukin-13; interleukin-13 precursor; L13; MGC116786; MGC116788; MGC116789; NC30; NC30 antibody; P600; P600 antibody; T-cell activation protein P600 |
Biological Activity | The ED50 as determined by the dose-dependent proliferation of TF-1 cells was ≤ 1.0 ng/ml, corresponding to a specific activity of ≥ 1 x 10^6 units/mg |
Gene ID (Entrez) | 3596 |
Formulation | protein with no preservative |
Recombinant | Recombinant |
Protein Family | Growth Factors & Receptors |
---|---|
Purity or Quality Grade | >95% by SDS-PAGE |
Conjugate | Unconjugated |
Form | Lyophilized |
Common Name | EGF |
Molecular Weight (g/mol) | 6.2 kDa |
Endotoxin Level | <0.1 ng/μg |
Endotoxin Concentration | <0.1 ng/ μg |
Expression System | E. coli |
For Use With (Application) | Control,ELISA,Functional Assay,Immunohistochemistry,Western Blot |
Name | Human EGF |
Purification Method | Sequential Chromatography |
Gene Alias | AI790464; beta-urogastrone; EGF; Epidermal growth factor; epidermal growth factor (beta-urogastrone); epidermal growth factor precursor; H-EGF; HOMG4; Pro-epidermal growth factor; Pro-epidermal growth factor precursor (EGF); sb:eu639; URG; Urogastrone |
Protein Form | Recombinant, Ligand |
Biological Activity | ED50 < 0.4 ng/mL; determined by the dose-dependent proliferation of mouse BALB/3T3 cells. |
Formulation | protein with no preservative |
Classification | Carrier-Free |
Research Category | Stem Cell Research, Oncology |
Species | Human |
Recombinant | Recombinant |
Shipping Condition | Wet Ice |
Content And Storage | 4°C |
Protein Subtype | EGF (Epidermal Growth Factor) |
Accession Number | P01133 |
Gene ID (Entrez) | 1950 |
Product Line | Gibco™ |